BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 5, 2009
View Archived Issues
Still No Winner in Acute HAE; FDA Wants New Cinryze Trial
Another runner has stumbled on a regulatory hurdle on the race to get the first acute hereditary angioedema (HAE) drug to market. (BioWorld Today)
Read More
With No Partner, Anadys Cuts Jobs and Raises $17M
Read More
New Study Describes Immune Mechanisms of Anaphylaxis
Read More
Experts: Health Reform Must Address Diabetes
Read More
Adolor Cuts Staff 28% to Focus on Entereg
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Appointments And Advancements
Read More